What is the recommended washout period when switching from semaglutide (glucagon-like peptide-1 receptor agonist) to tirzepatide (dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist) for a patient with potential type 2 diabetes, obesity, and a chronic inflammatory condition?
Key aspects are low sodium, high fiber, lean protein, whole grains, non-starchy vegetables, and low glycemic index fruit to promote improved blood glucose balance and a healthy blood pressure
Boosting Your Results In addition to foundational support, some may seek an extra edge in their energy levels and metabolic function
View source Mounjaro prescribing information FDA-approved prescribing information for tirzepatide as Mounjaro
Recognition from Independent Review Platform Online Therapist AIs review recognized CoreAge Rx for excelling across several areas that matter most to patients seeking GLP-1 therapy